Chemokines and the extracellular matrix: Set of targets for tumor development and treatment
出版年份 2021 全文链接
标题
Chemokines and the extracellular matrix: Set of targets for tumor development and treatment
作者
关键词
Chemokines, Tumor, Extracellular matrix, Recruitment, Adherence, Progress
出版物
CYTOKINE
Volume -, Issue -, Pages 155548
出版商
Elsevier BV
发表日期
2021-05-08
DOI
10.1016/j.cyto.2021.155548
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cytokines and Chemokines as Mediators of Prostate Cancer Metastasis
- (2020) Timothy O. Adekoya et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mogamulizumab: a new tool for management of cutaneous T-cell lymphoma
- (2019) Thomas A Ollila et al. OncoTargets and Therapy
- The Expression of the Chemokine CXCL14 Correlates with Several Aggressive Aspects of Glioblastoma and Promotes Key Properties of Glioblastoma Cells
- (2019) Barbara Fazi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CXCR4 antagonism in combination with IDO1 inhibition weakens immune suppression and inhibits tumor growth in mouse breast cancer bone metastases
- (2019) Jian Zhang et al. OncoTargets and Therapy
- The Role of the Extracellular Matrix in Cancer Stemness
- (2019) Sameera Nallanthighal et al. Frontiers in Cell and Developmental Biology
- Macrophage Exclusion after Radiation Therapy (MERT): A First in Human Phase I/II Trial using a CXCR4 Inhibitor in Glioblastoma
- (2019) Reena P Thomas et al. CLINICAL CANCER RESEARCH
- A Phase I Study of the Anti-CC Chemokine Receptor 4 Antibody, Mogamulizumab, in Combination with Nivolumab in Patients with Advanced or Metastatic Solid Tumors
- (2019) Toshihiko Doi et al. CLINICAL CANCER RESEARCH
- A Phase Ib/II Trial of the First-in-Class Anti-CXCR4 Antibody Ulocuplumab in Combination with Lenalidomide or Bortezomib Plus Dexamethasone in Relapsed Multiple Myeloma
- (2019) Irene M. Ghobrial et al. CLINICAL CANCER RESEARCH
- IL8 Expression Is Associated with Prostate Cancer Aggressiveness and Androgen Receptor Loss in Primary and Metastatic Prostate Cancer
- (2019) Janielle P. Maynard et al. MOLECULAR CANCER RESEARCH
- The CXCL5/CXCR2 axis is sufficient to promote breast cancer colonization during bone metastasis
- (2019) Ricardo Romero-Moreno et al. Nature Communications
- Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models
- (2019) Sarah Greene et al. CLINICAL CANCER RESEARCH
- Targeting the CXCL12/CXCR4 pathway and myeloid cells to improve radiation treatment of locally advanced cervical cancer
- (2018) Magali Lecavalier-Barsoum et al. INTERNATIONAL JOURNAL OF CANCER
- Opposing Functions of Heparanase-1 and Heparanase-2 in Cancer Progression
- (2018) Israel Vlodavsky et al. TRENDS IN BIOCHEMICAL SCIENCES
- Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation
- (2018) Mana Taki et al. Nature Communications
- Abstract CT124: A phase Ib/II study of BMS-813160, a CC chemokine receptor (CCR) 2/5 dual antagonist, in combination with chemotherapy or nivolumab in patients (pts) with advanced pancreatic or colorectal cancer
- (2018) Dung Le et al. CANCER RESEARCH
- Abstract 3760: Preclinical antitumor activity of a CC chemokine receptor (CCR) 2/5 dual antagonist as monotherapy and in combination with immune checkpoint blockade
- (2018) Qihong Zhao et al. CANCER RESEARCH
- Doxycycline down-regulates matrix metalloproteinase expression and inhibits NF-κB signaling in LPS-induced PC3 cells
- (2017) Deniz Ogut et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- Extracellular matrix structure
- (2016) Achilleas D. Theocharis et al. ADVANCED DRUG DELIVERY REVIEWS
- Expression of the chemokine CXCL14 in the tumour stroma is an independent marker of survival in breast cancer
- (2016) Elin Sjöberg et al. BRITISH JOURNAL OF CANCER
- Matrix control of pancreatic cancer: New insights into fibronectin signaling
- (2016) Mary Topalovski et al. CANCER LETTERS
- Chemokines: Chemistry, Biochemistry and Biological Function
- (2016) DanielF. Legler et al. CHIMIA
- CXCL14 as an emerging immune and inflammatory modulator
- (2016) Jing Lu et al. Journal of Inflammation-London
- Ulocuplumab (BMS-936564 / MDX1338): a fully human anti-CXCR4 antibody induces cell death in chronic lymphocytic leukemia mediated through a reactive oxygen species-dependent pathway
- (2015) Manoj K. Kashyap et al. Oncotarget
- Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and Inflammation
- (2015) Selma Rivas-Fuentes et al. Journal of Cancer
- AMD3100/CXCR4 Inhibitor
- (2015) Erik De Clercq Frontiers in Immunology
- Cancer-Associated Fibroblasts Expressing CXCL14 Rely upon NOS1-Derived Nitric Oxide Signaling for Their Tumor-Supporting Properties
- (2014) M. Augsten et al. CANCER RESEARCH
- Myeloid IKK Promotes Antitumor Immunity by Modulating CCL11 and the Innate Immune Response
- (2014) J. Yang et al. CANCER RESEARCH
- The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases
- (2014) Remo C Russo et al. Expert Review of Clinical Immunology
- IL-22+CD4+ T Cells Promote Colorectal Cancer Stemness via STAT3 Transcription Factor Activation and Induction of the Methyltransferase DOT1L
- (2014) Ilona Kryczek et al. IMMUNITY
- CXCR3 deficiency enhances tumor progression by promoting macrophage M2 polarization in a murine breast cancer model
- (2014) Steve Oghumu et al. IMMUNOLOGY
- Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study
- (2014) Irene Brana et al. Targeted Oncology
- The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics
- (2014) Edward Hammond et al. Frontiers in Oncology
- Matricellular proteins: priming the tumour microenvironment for cancer development and metastasis
- (2013) G S Wong et al. BRITISH JOURNAL OF CANCER
- A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors
- (2013) Shahneen K. Sandhu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Extracellular matrix signaling in morphogenesis and repair
- (2013) Kelly C Clause et al. CURRENT OPINION IN BIOTECHNOLOGY
- Protective Role of the Inflammatory CCR2/CCL2 Chemokine Pathway through Recruitment of Type 1 Cytotoxic T Lymphocytes to Tumor Beds
- (2013) T. Lanca et al. JOURNAL OF IMMUNOLOGY
- Integrin Regulation during Leukocyte Recruitment
- (2013) J. Herter et al. JOURNAL OF IMMUNOLOGY
- Inflammatory chemokines and metastasis—tracing the accessory
- (2013) L Borsig et al. ONCOGENE
- Recruitment of γδ T lymphocytes to tumors
- (2013) Telma Lança et al. OncoImmunology
- A role for CCL2 in both tumor progression and immunosurveillance
- (2013) Ming Li et al. OncoImmunology
- Endothelial CCR2 Signaling Induced by Colon Carcinoma Cells Enables Extravasation via the JAK2-Stat5 and p38MAPK Pathway
- (2012) Monika Julia Wolf et al. CANCER CELL
- The Chemokine Superfamily Revisited
- (2012) Albert Zlotnik et al. IMMUNITY
- Structural basis for high selectivity of anti-CCL2 neutralizing antibody CNTO 888
- (2012) Galina Obmolova et al. MOLECULAR IMMUNOLOGY
- The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer
- (2011) Ji-Yu Li et al. BREAST CANCER RESEARCH AND TREATMENT
- Tumor Entrained Neutrophils Inhibit Seeding in the Premetastatic Lung
- (2011) Zvi Granot et al. CANCER CELL
- Maximal T Cell-Mediated Antitumor Responses Rely upon CCR5 Expression in Both CD4+ and CD8+ T Cells
- (2011) A. Gonzalez-Martin et al. CANCER RESEARCH
- CXCL12-CXCR4 Axis in Angiogenesis, Metastasis and Stem Cell Mobilization
- (2011) S. Liekens et al. CURRENT PHARMACEUTICAL DESIGN
- Chemokines in health and disease
- (2011) Dayanidhi Raman et al. EXPERIMENTAL CELL RESEARCH
- Annexin-1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-κB: implication in breast cancer metastasis
- (2011) P Bist et al. ONCOGENE
- Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature
- (2010) Michael O. Griffin et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression
- (2010) Xueqing Sun et al. CANCER AND METASTASIS REVIEWS
- Breast Cancer Cells in Three-dimensional Culture Display an Enhanced Radioresponse after Coordinate Targeting of Integrin 5 1 and Fibronectin
- (2010) J.-M. Nam et al. CANCER RESEARCH
- Plasma Fibronectin Promotes Lung Metastasis by Contributions to Fibrin Clots and Tumor Cell Invasion
- (2010) Gunjan Malik et al. CANCER RESEARCH
- The extracellular matrix at a glance
- (2010) C. Frantz et al. JOURNAL OF CELL SCIENCE
- Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
- (2010) Subhra K Biswas et al. NATURE IMMUNOLOGY
- Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis
- (2010) M Tessema et al. ONCOGENE
- Therapy with Nonglycosaminoglycan-Binding Mutant CCL7: A Novel Strategy to Limit Allograft Inflammation
- (2009) S. Ali et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Pharmacology of AMD3465: A small molecule antagonist of the chemokine receptor CXCR4
- (2009) Veronique Bodart et al. BIOCHEMICAL PHARMACOLOGY
- CCL5-Mediated Endogenous Antitumor Immunity Elicited by Adoptively Transferred Lymphocytes and Dendritic Cell Depletion
- (2009) Y. Nesbeth et al. CANCER RESEARCH
- Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
- (2009) H. Harlin et al. CANCER RESEARCH
- Chemokine (C-C Motif) Ligand 2 Engages CCR2+Stromal Cells of Monocytic Origin to Promote Breast Cancer Metastasis to Lung and Bone
- (2009) Xin Lu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth
- (2009) M. Augsten et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The role of tenascin-C in tissue injury and tumorigenesis
- (2009) Kim S. Midwood et al. Journal of Cell Communication and Signaling
- Natural Killer Cell Accumulation in Tumors Is Dependent on IFN- and CXCR3 Ligands
- (2008) M. Wendel et al. CANCER RESEARCH
- Relationships between glycosaminoglycan and receptor binding sites in chemokines—the CXCL12 example
- (2008) Cédric Laguri et al. CARBOHYDRATE RESEARCH
- The Structure of Glycosaminoglycans and their Interactions with Proteins
- (2008) Neha S. Gandhi et al. Chemical Biology & Drug Design
- Biomechanical regulation of cell orientation and fate
- (2008) J I Lopez et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started